Close this search box.

Clinical Trial: SWOG LUNGMAP


Status: Open

A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)
A screening trial for S1800A (closed), S1900A (closed), S1900C (closed), S1900E,   S1900G, and S1900K.

Eligible for screening study DCP 001

LUNGMAP participants with KRASG12c and TP53 mutations and Wild Type STK11, KEAP1, NFE2L2, AND CUL3 will no longer be assigned to S1900E, effective December 13, 2023.

Effective, June 30th, 2019, the sub-study S1400GEN is closed to accrual.